Showing 6-10 of 25 news & articles:
New Harmonized Outcome Measures for Atrial Fibrillation Published in HeartRhythm

November 15, 2018 —OM1, a leading health outcomes and technology company, today announced the publication of new harmonized outcome measures for atrial fibrillation (AF) in HeartRhythm.  OM1’s Richard Gliklich and Michelle Leavy collaborated on the development of the measures and co-authored the publication. The work was funded by the Agency for Healthcare Research and Quality (AHRQ) through[…]

OM1 Lupus Registry Reaches More Than 25,000 Patients Prospectively Followed With Deep Clinical And Lab Data

OM1 LUPUS REGISTRY REACHES MORE THAN 25,000 PATIENTS PROSPECTIVELY FOLLOWED WITH DEEP CLINICAL AND LAB DATA Ready for collaborations, the registry enables faster, more cost-effective access to research-grade lupus data for better understanding, comparing, and predicting treatment outcomes BOSTON, October 17, 2018 — OM1, a leading health outcomes, registries and technology company creating solutions to[…]

Achieving a Win-Win for Pharma and Payers in Contracting Agreements

Published on PM360, April 2, 2018 The shift to value-based care and outcomes contracting type programs present the opportunity to align stakeholder interests around value and demonstrate a commitment to improving clinical and cost outcomes. From earlier detection to more precision management, the opportunities for pharma to partner around outcomes and value are growing. Win-wins[…]

New AHRQ E-Book on Patient Registry Issues Developed Under OM1 Contract

BOSTON, March 19, 2018 — The U.S. Agency for Healthcare Research and Quality (AHRQ) today announced the release of a series of publications on the evolving role of patient registries, including increasing the patient focus. Under contract to AHRQ and L&M Policy Research, OM1, a leading health outcomes and registries company focused on the measurement,[…]